genOway Société anonyme (ALGEN.PA)

EUR 3.92

(0.0%)

Market Cap (In EUR)

35.08 Million

Revenue (In EUR)

20.04 Million

Net Income (In EUR)

1.56 Million

Avg. Volume

4729.00

Currency
EUR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.24-4.91
PE
-
EPS
-
Beta Value
0.55
ISIN
FR0004053510
CUSIP
F8348K103
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Alexandre Fraichard
Employee Count
-
Website
https://www.genoway.com
Ipo Date
2007-05-07
Details
genOway Société anonyme, a biotechnology company, develops, manufactures, commercializes, and sells of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoint mouse models; immunodeficient and reconstituted mouse and rat strains models; humanized immune target models; other mouse and rat catalog models; and immune checkpoint catalog cell lines. It serves pharmaceutical and life science companies, and academic institutes. The company was founded in 1999 and is headquartered in Lyon, France.